SCHEMBL9358190

SCHEMBL9358190

O=C1CN(C(=O)OC(Cc2ccccc2)C(=O)OCc2ccccc2)CCN1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.47
RAB9A P51151 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
GAA P10253 2/20 0.43
NPC1 O15118 2/20 0.43
MAPK1 P28482 2/20 0.43
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
NPSR1 Q6W5P4 1/20 0.40
GLA P06280 1/20 0.39
TSHR P16473 1/20 0.38
CYP2C19 P33261 1/20 0.38
PARP1 P09874 1/20 0.38
MAPT P10636 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
PPARG P37231 1/20 0.38
PPARA Q07869 1/20 0.38
CTRB1 P17538 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9358195 1.00 L3MBTL1 (0.47) L3MBTL1RAB9ASMN1; SMN2GAANPC1
SCHEMBL9355125 0.89 L3MBTL1 (0.51) L3MBTL1RAB9AMAPK1MEN1KMT2A
SCHEMBL9355132 0.89 L3MBTL1 (0.51) L3MBTL1RAB9AMAPK1MEN1KMT2A
SCHEMBL92518 0.84 L3MBTL1 (0.56) L3MBTL1RAB9ASMN1; SMN2GAANPC1
SCHEMBL9358829 0.83 MEN1 (0.42) L3MBTL1RAB9ASMN1; SMN2GAANPC1
SCHEMBL9358821 0.83 MEN1 (0.42) L3MBTL1RAB9ASMN1; SMN2GAANPC1
SCHEMBL9354726 0.81 CYP2C19 (0.45) L3MBTL1RAB9ASMN1; SMN2GAANPC1
SCHEMBL9354731 0.81 CYP2C19 (0.45) L3MBTL1RAB9ASMN1; SMN2GAANPC1
SCHEMBL9354656 0.80 TMEM97 (0.40) RAB9ASMN1; SMN2GAANPC1MAPK1
SCHEMBL9354661 0.80 TMEM97 (0.40) RAB9ASMN1; SMN2GAANPC1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0300189-B1 New amino acid derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO (JP) 1994-11-02 EP disclosed
US-5223489-A Treatment of ypertension and heart failure UJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-06-29 US disclosed
US-5142048-A Enzyme inhibitor; carbamoyl group-containing acids FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1992-08-25 US disclosed
EP-0300189-A2 New amino acid derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-01-25 EP disclosed